TotalMarketCap

iBio

IBIONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$47.369 M

$0.74 -7.92%

Close of 6 Nov 2026

As of 6 Nov 2026, iBio (IBIO) has a market capitalization of $47.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$400.0K

#3521 by revenue

Earnings

-$18.4M

Loss-making

Shares outstanding

64,307,256

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #339OS TherapiesOSTX$47.9M
  2. #340MindWalkHYFT$47.6M
  3. #341iBioIBIO$47.4M
  4. #342Citius OncologyCTOR$47.1M
  5. #343Connect BiopharmaCNTB$46.0M

What if iBio were worth as much as…

Open the what-if tool →

Gold $28.2T

$439,093.12

Per share 596,108× higher

Bitcoin $1.53T

$23,758.56

Per share 32,254× higher

Apple $5.02T

$77,997.15

Per share 105,888× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for iBio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.